ZENIQUIN TABLETS 100MG

Nchi: Australia

Lugha: Kiingereza

Chanzo: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
20-06-2017
Tabia za bidhaa Tabia za bidhaa (SPC)
20-06-2017

Viambatanisho vya kazi:

MARBOFLOXACIN

Inapatikana kutoka:

ZOETIS AUSTRALIA PTY LTD

INN (Jina la Kimataifa):

marbofloxacin(100mg/Tb)

Dawa fomu:

ORAL TABLET

Tungo:

MARBOFLOXACIN ANTIBIOTIC Active 100.0 mg/Tb

Vitengo katika mfuko:

50 Tablets

Darasa:

VM - Veterinary Medicine

Viwandani na:

ZOETIS AUSTRALIA

Kundi la matibabu:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Eneo la matibabu:

ANTIBIOTIC & RELATED

Matibabu dalili:

BACILLUS SPP. | BETA-HEMOLYTIC STREPTOCOCCUS (NOT A OR B | CORYNEBACTERIUM SPP. | ENTEROCOCCUS FAECALIS | ESCHERICHIA COLI (E. COLI) | INFECTIONS OF THE SKIN | INFECTIONS OF THE URINARY TRACTS | KLEBSIELLA PNEUMONIAE | PASTEURELLA MULTOCIDA | PROTEUS MIRABILIS | PSEUDOMONAS AERUGINOSA | PSEUDOMONAS SPP. | SOFT TISSUE INFECTIONS | STAPHYLOCOCCUS AUREUS | STAPHYLOCOCCUS INTERMEDIUS | STREPTOCOCCUS SPP. | ABSCESSES | ANAL SACCULITIS | BACTERIAL CANKER | DEEP PYODERMAS | ESCHERICHIA COLI | FOWL CHOLERA | FUNGAL | GINGIVITIS | GRAM NEGATIVE BACTERIA | GRAM POSITIVE BACTERIA | GROUP D STREPTOCOCCUS | INCLUDING B-LACTAMASE PRODUCIN | INCLUDING SECONDARY INVADERS | KLEBSIELLA SPP. | NOT GROUP A | NOT GROUP B | POST-PARTURIENT INFECTIONS | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | PYODERMA | SEBORRHOEIC DERMATITIS | SEPTICAEMIA | STAPHYLOCOCCUS SPP. | YEAST

Bidhaa muhtasari:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [BACILLUS SPP., BETA-HEMOLYTIC STREPTOCOCCUS (NOT A OR B, CORYNEBACTERIUM SPP., ENTEROCOCCUS FAECALIS, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE SKIN, PASTEURELLA MULTOCIDA, SOFT TISSUE INFECTIONS, STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS INTERMEDIUS]; DOG: [BETA-HEMOLYTIC STREPTOCOCCUS (NOT A OR B, ENTEROCOCCUS FAECALIS, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE SKIN, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA PNEUMONIAE, PASTEURELLA MULTOCIDA, PROTEUS MIRABILIS, PSEUDOMONAS AERUGINOSA, PSEUDOMONAS SPP., SOFT TISSUE INFECTIONS, STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS SPP.]; For the treatment in dogs of skin, soft tissue and urinary tract infections caused by organisms susceptible to marbofloxacin.

Idhini hali ya:

Registered

Idhini ya tarehe:

2022-07-01

Taarifa za kipeperushi

                                LABEL IMAGE PROUDLY SUPPLIED BY
INFOPEST@DPI.QLD.GOV.AU
                                
                                Soma hati kamili
                                
                            

Tabia za bidhaa

                                PRODUCT NAME: ZENIQUIN TABLETS
PAGE: 1 OF 5
This revision issued: September, 2011
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: 1800 814 883
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: 1800 814 883
Fax: (02) 9850 3399
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
CHEMICAL NATURE:
Blend of ingredients (see below). Active ingredient is antibacterial.
TRADE NAME:
ZENIQUIN TABLETS
PRODUCT USE:
Antibacterial preparation used in veterinary applications.
CREATION DATE:
JULY, 2006
THIS VERSION ISSUED:
SEPTEMBER, 2011
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Xn, Harmful. Hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R43, R62, R48/22. May cause sensitisation by skin contact. Possible
risk of impaired fertility.
Harmful: danger of serious damage to health by prolonged exposure if
swallowed.
SAFETY PHRASES:
S20, S22, S28, S36, S53. When using, do not eat or drink. Do not
breathe dust. After contact with
skin, wash immediately with plenty of soap and water. Wear suitable
protective clothing. Avoid exposure - obtain
special instructions before use.
SUSMP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Beige coloured film-coated tablets.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
possible skin sensitiser, possible risk of impaired fertility. A
significant ingredient is an
antibiotic. Any person with a history of allergies to this class of
substances should avoid all contact with this product
as it may cause sensiti
                                
                                Soma hati kamili